¼¼°èÀÇ ¼Ò¾Æ ¿ÏÈ­ ÄÉ¾î ½ÃÀå
Pediatric Palliative Care
»óǰÄÚµå : 1788255
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 290 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,233,000
PDF & Excel (Single User License) help
PDF & Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÆÄÀÏ ³» ÅØ½ºÆ®ÀÇ º¹»ç ¹× ºÙ¿©³Ö±â´Â °¡´ÉÇÏÁö¸¸, Ç¥/±×·¡ÇÁ µîÀº º¹»çÇÒ ¼ö ¾ø½À´Ï´Ù. Àμâ´Â 1ȸ °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë¹üÀ§´Â ÆÄÀÏ ÀÌ¿ë¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,701,000
PDF & Excel (Global License to Company and its Fully-owned Subsidiaries) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ¹× 100% ÀÚȸ»çÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÏ½Ç ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â 1Àδç 1ȸ °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë¹üÀ§´Â ÆÄÀÏ ÀÌ¿ë¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ ¼Ò¾Æ ¿ÏÈ­ ÄÉ¾î ½ÃÀåÀº 2030³â±îÁö 216¾ï ´Þ·¯¿¡ µµ´Þ

2024³â¿¡ 113¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼¼°èÀÇ ¼Ò¾Æ ¿ÏÈ­ ÄÉ¾î ½ÃÀåÀº 2024-2030³âÀÇ ºÐ¼® ±â°£¿¡ CAGR 11.4%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 216¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ ¸®Æ÷Æ®¿¡¼­ ºÐ¼®ÇÑ ºÎ¹®ÀÇ ÇϳªÀÎ HIV´Â CAGR 11.2%¸¦ ±â·ÏÇϸç, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 90¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. Á¶»ê¡¤¿Ü»ó ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ Áß CAGR 13.0%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 31¾ï ´Þ·¯, Áß±¹Àº CAGR 15.4%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹Ãø

¹Ì±¹ÀÇ ¼Ò¾Æ ¿ÏÈ­ ÄÉ¾î ½ÃÀåÀº 2024³â¿¡ 31¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 45¾ï ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³âÀÇ CAGRÀº 15.4%ÀÔ´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 8.3%¿Í 10.1%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR ¾à 9.0%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ ¼Ò¾Æ ¿ÏÈ­ ÄÉ¾î ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

Àü ¼¼°è ¼Ò¾Æ ÀÇ·á ¼­ºñ½º¿¡¼­ ¼Ò¾Æ ¿ÏÈ­Ä¡·á°¡ ±ÞÁõÇÏ´Â ÀÌÀ¯´Â ¹«¾ùÀΰ¡?

½Å»ý¾Æ ¹× ¼Ò¾Æ ÀÇ·áÀÇ ¹ßÀüÀ¸·Î ´õ ¸¹Àº ¾î¸°À̵éÀÌ »ý¸íÀ» À§ÇùÇÏ´Â »óȲ¿¡ óÇÏ°Ô µÇ¸é¼­, ¼Ò¾Æ ¿ÏÈ­ Ä¡·á(PPC)´Â Çö´ë ÀÇ·á ½Ã½ºÅÛ¿¡¼­ Á¡Á¡ ´õ ÇʼöÀûÀÎ ¿ä¼Ò·Î ÀÚ¸® Àâ°í ÀÖ½À´Ï´Ù. ÁÖ·Î ¸»±â Áö¿ø¿¡ ÁßÁ¡À» µÎ´Â ¼ºÀÎ ¿ÏÈ­Ä¡·á¿Í´Â ´Þ¸®, PPC´Â Áø´ÜºÎÅÍ ½ÃÀÛÇÏ¿© Ä¡·á¿Í º´ÇàÇϸç, ¾Æµ¿°ú °¡Á· ¸ðµÎ¿¡°Ô ½ÅüÀû, Á¤½ÅÀû, ½É¸®Àû, ¿µÀû µ¹º½À» °­Á¶ÇÕ´Ï´Ù. ¼±Ãµ¼º ±âÇü, ¼Ò¾Æ¾Ï, ÁßÁõ ½Å°æÁúȯ, ´ë»ç¼º Áúȯ, Èñ±Í À¯Àü ÁõÈıº µîÀÇ ÁúȯÀº Æí¾ÈÇÔ, Á¸¾ö¼º, »îÀÇ ÁúÀ» ¿ì¼±½ÃÇÏ´Â Áö¼ÓÀû À̰í Á¾ÇÕÀûÀÎ Äɾî Ç÷£ÀÌ ÇÊ¿äÇÕ´Ï´Ù. Àü ¼¼°è¿¡¼­ ¿¬°£ 2,100¸¸ ¸íÀÇ ¾î¸°À̰¡ ¿ÏÈ­Ä¡·á°¡ ÇÊ¿äÇÑ °ÍÀ¸·Î Ãß»êµÇÁö¸¸, ƯÈ÷ ÁßÀú¼Òµæ ±¹°¡¿¡¼­´Â Á¢±Ù¼ºÀÌ ¸Å¿ì ºÒÆòµîÇÑ ½ÇÁ¤ÀÔ´Ï´Ù. ÅëÁõ ¿ÏÈ­, ½É¸®»çȸÀû Áö¿ø, ¹è·Á¿¡ ´ëÇÑ ¾Æµ¿ÀÇ ±Ç¸®°¡ Àνĵʿ¡ µû¶ó Á¤ºÎ, NGO, ÀÇ·á ±â°üÀº PPCÀÇ ¿ª·®À» È®´ëÇÒ °ÍÀ» ¿ä±¸¹Þ°í ÀÖ½À´Ï´Ù. ¼Ò¾ÆÀÇ »ýÁ¸À²ÀÌ Çâ»óµÊ¿¡ µû¶ó ¸¸¼ºÈ­, Á¤¼­Àû º¹À⼺, °¡Á· Âü¿©¸¦ °í·ÁÇÑ Áö¼Ó°¡´ÉÇÑ ÄÉ¾î ¸ðµ¨ÀÇ Çʿ伺µµ Áõ°¡Çϰí ÀÖÀ¸¸ç, PPC´Â ¼Ò¾Æ ÀÇ·á ¼­ºñ½ºÀÇ Áö¼Ó¼º¿¡ ÀÖÀ¸¸ç, Áß¿äÇÑ ÃàÀÌ µÇ°í ÀÖ½À´Ï´Ù.

ÅëÇÕ Áø·á ¸ðµ¨°ú ´ÙÇÐÁ¦ ÆÀÀº PPC Á¦°øÀ» ¾î¶»°Ô º¯È­½Ã۰í Àִ°¡?

¼Ò¾Æ ¿ÏÈ­Ä¡·á Á¦°øÀº ¼Ò¾Æ ȯÀÚ¿Í ±× °¡Á·ÀÇ ´Ù¸éÀû ¿ä±¸¸¦ ÃæÁ·½Ã۱â À§ÇØ °í¾ÈµÈ ÅëÇÕÀû Ä¡·á ¸ðµ¨°ú ´ÙÇÐÁ¦Àû Çù¾÷À» ÅëÇØ ÁøÈ­Çϰí ÀÖ½À´Ï´Ù. ±âÁ¸ÀÇ ÀÇ·á ¼­ºñ½º¿Í´Â ´Þ¸®, PPC´Â ¼Ò¾Æ°ú ÀÇ»ç, °£È£»ç, ÅëÁõ Àü¹®°¡, ½É¸®ÇÐÀÚ, »çȸº¹Áö»ç, äÇø°, ¿ÏÈ­Ä¡·á Àü¹®°¡ µîÀ¸·Î ±¸¼ºµÈ ±ä¹ÐÇÑ ÆÀÀÌ Çù·ÂÇÏ¿© ¾Æµ¿ÀÇ ÇູÀÇ ¸ðµç Ãø¸éÀ» Áö¿øÇÕ´Ï´Ù. ÀÌ ÆÀÀº 1Â÷ÀÇ·á, Á¾¾ç°ú, ¼øÈ¯±â³»°ú, ½Å°æ°ú, ÁßȯÀÚ½Ç µî Àü¹® ¼­ºñ½º, º´¿ø, È£½ºÇǽº, ±×¸®°í ÃÖ±Ù¿¡´Â ¾î¸°ÀÌ Áý µî ¸ðµç °÷¿¡¼­ ¿¬¼Ó¼ºÀ» º¸ÀåÇϰí ÀÖ½À´Ï´Ù. ¿ø°ÝÀÇ·á¿Í ¿ø°Ý ¸ð´ÏÅ͸µ¿¡ ±â¹ÝÇÑ ÀçÅà ¿ÏÈ­Ä¡·á ¼­ºñ½ºÀÇ µîÀåÀ¸·Î ¾ÆÀ̵éÀº Àͼ÷ÇÑ È¯°æ¿¡¼­ ¾çÁúÀÇ °³º°È­µÈ µ¹º½À» ¹ÞÀ» ¼ö ÀÖ°Ô µÇ¾ú°í, ÀÔ¿ø ±â°£À» ÃÖ¼ÒÈ­ÇÏ°í Æí¾ÈÇÔÀ» ±Ø´ëÈ­ÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ¶ÇÇÑ ºÎ¸ð¿Í °£º´ÀÎÀÌ ÀÇ»ç°áÁ¤ °úÁ¤°ú »çº° Áö¿ø¿¡ Âü¿©ÇÔÀ¸·Î½á °¡Á· Áß½ÉÀÇ Äɾ PPC Á¦°øÀÇ Áß½ÉÀÌ µÇ°í ÀÖ½À´Ï´Ù. ÀÇ·á Àü¹®°¡¿¡ ´ëÇÑ ±³À° ¹× ÈÆ·Ãµµ È®´ëµÇ°í ÀÖÀ¸¸ç, PPC¿¡ ÃÊÁ¡À» ¸ÂÃá Ä¿¸®Å§·³°ú ÀÚ°ÝÁõÀ» Á¦°øÇÏ´Â ÀÇ·á ±â°üÀº ±â¼ú Çâ»ó°ú Ä¡·á Ç¥ÁØÈ­¸¦ À§ÇØ ³ë·ÂÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¾ÇÕÀûÀÌ°í °ø°¨ÀûÀ̸ç Çù·ÂÀûÀÎ Á¢±Ù ¹æ½ÄÀº ¼Ò¾Æ ÇコÄɾîÀÇ »õ·Î¿î º¥Ä¡¸¶Å· ´ë»óÀÌ µÇ°í ÀÖÀ¸¸ç, ÁßÁõ ¾Æµ¿À» µ¹º¸´Â µ¥ ÇÊ¿äÇÑ º¹À⼺°ú ¼¶¼¼ÇÔÀ» ¹Ý¿µÇϰí ÀÖ½À´Ï´Ù.

PPC °³¹ß¿¡¼­ ¼¼°è º¸°Ç Á¤Ã¥, ¿ËÈ£, °øÁ¤¼ºÀº ¾î¶² ¿ªÇÒÀ» Çϴ°¡?

¼¼°è º¸°Ç Á¤Ã¥, ÀεµÁÖÀÇÀû ¿ËÈ£, °øÆòÇÑ Á¢±ÙÀÇ ÃËÁøÀº ¼Ò¾Æ ¿ÏÈ­Ä¡·á ¼­ºñ½º °³¹ß¿¡¼­ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ¼¼°èº¸°Ç±â±¸(WHO), À¯´Ï¼¼ÇÁ(UNICEF), ±¹Á¦¾Æµ¿¿ÏÈ­Ä¡·á³×Æ®¿öÅ©(ICPCN) µî ±¹Á¦±â±¸´Â °¢±¹ÀÌ PPC¸¦ ±¹°¡ º¸°Ç Àü·«¿¡ Æ÷ÇÔÇϵµ·Ï Àå·ÁÇÏ´Â Á¤Ã¥ ÇÁ·¹ÀÓ¿öÅ©¸¦ ÃßÁøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ³ë·ÂÀº ¿ÏÈ­Ä¡·á°¡ ÀÇÇÐÀûÀ¸·Î ÇÊ¿äÇÑ °ÍÀÏ »Ó¸¸ ¾Æ´Ï¶ó ÀαÇÀ̶ó´Â Áõ°Å¿¡ ÀÇÇØ Áö¿øµÇ°í ÀÖ½À´Ï´Ù. °í¼Òµæ ±¹°¡¿¡¼­´Â Àü¹® PPC À¯´Ö°ú Àü¿ë È£½ºÇǽº°¡ µîÀåÇϰí ÀÖÁö¸¸, ÀúÀÚ¿ø ±¹°¡¿¡¼­´Â ±âº»ÀûÀÎ ¿ÏÈ­Ä¡·á ¼­ºñ½ºÁ¶Â÷µµ ¾ÆÁ÷ ºÎÁ·ÇÑ ½ÇÁ¤ÀÔ´Ï´Ù. ÀÌ¿¡ ¹ÝÇØ NGO, ÀÚ¼±Àç´Ü, Áö¿ª»çȸ ´ÜüµéÀº Ç®»Ñ¸® PPC ÇÁ·Î±×·¥¿¡ ÀÚ±ÝÀ» Áö¿øÇϰí, ÀÎÀûÀÚ¿ø °³¹ß, »çȸÀû ÀνÄ, Á¤Ã¥ Âü¿©¸¦ ÅëÇØ Áö¿ª»çȸÀÇ ¿ª·®À» °­È­Çϱâ À§ÇØ ³ë·ÂÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ Á¾±³ ¹× ¹®È­ ÁöµµÀÚµéÀÇ Âü¿©°¡ Áõ°¡Çϸ鼭 º¸¼öÀûÀ̰ųª ¼Ò¿ÜµÈ Áö¿ª»çȸÀÇ ³«ÀÎÀ» ÁÙÀÌ°í ¿ÏÈ­Ä¡·á¿¡ ´ëÇÑ ¹®È­Àû ¼ö¿ë¼ºÀ» °³¼±ÇÏ´Â µ¥ µµ¿òÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¼Ò¾Æ±âÀÇ °íÅëÀ» ÁÙÀÌ°í °øÆòÇÑ Ä¡·á Á¢±ÙÀ» ÃËÁøÇÏ´Â µ¥ Àü ¼¼°èÀÇ °ü½ÉÀÌ ÁýÁߵǰí ÀÖ´Â °¡¿îµ¥, Á¤Ã¥, ÀçÁ¤ Áö¿ø, ¿ËÈ£ Ȱµ¿Àº Àü ¼¼°è¿¡¼­ ¼Ò¾Æ ¿ÏÈ­Ä¡·áÀÇ È®´ë¿Í Á¦µµÈ­¿¡ ¸Å¿ì Áß¿äÇÕ´Ï´Ù.

¼Ò¾Æ ¿ÏÈ­Ä¡·á ½ÃÀåÀÇ ¼ºÀå ÃËÁø¿äÀÎÀº?

¼Ò¾Æ ¿ÏÈ­Ä¡·á ½ÃÀåÀÇ ¼ºÀåÀº Áúº´ À¯Çà, ÀÇ·á ¹ßÀü, Á¤Ã¥ ÅëÇÕ, »çȸ °¡Ä¡°üÀÇ º¯È­ µî°ú °ü·ÃµÈ ¸î °¡Áö Áß¿äÇÑ ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ù°, ¸¸¼ºÀûÀÌ°í º¹ÀâÇÑ ÁúȯÀ» ¾Î°í ÀÖ´Â ¼Ò¾ÆÀÇ »ýÁ¸À²ÀÌ ³ô¾ÆÁ® Àå±âÀûÀÎ ¿ÏÈ­ Áö¿øÀÌ ÇÊ¿äÇÑ Àα¸°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. µÑ°, ¼Ò¾ÆÁ¾¾çÇÐ, ½Å°æÇÐ, ½Å»ý¾ÆÇÐ µî ¼Ò¾Æ°ú ÇÏÀ§ Àü¹®ºÐ¾ßÀÇ È®´ë´Â Áúº´ Àü¹Ý¿¡ °ÉÄ£ Ä¡·áÀû Ä¡·á¸¦ º¸¿ÏÇÏ´Â ¿ÏÈ­Ä¡·á Àü¹®Áö½Ä¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¼Â°, µðÁöÅÐ Çコ Ç÷§Æû¿¡ ±â¹ÝÇÑ ÀçÅÃÀÇ·á ¹× Áö¿ª Á᫐ ÄÉ¾î ¸ðµ¨ÀÇ Ã¤ÅÃÀÌ È®´ëµÇ¸é¼­ PPCÀÇ È®À强°ú Ȱ¿ëµµ°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ³Ý°, ¸»±â»Ó¸¸ ¾Æ´Ï¶ó Áúº´ °æ°ú Àü¹Ý¿¡ °ÉÃÄ ÃʱâºÎÅÍ ¿ÏÈ­Ä¡·á¿¡ °³ÀÔÇÏ´Â °ÍÀÇ ÀÌÁ¡¿¡ ´ëÇÑ Àνİú ±³À°ÀÌ Àü ¼¼°è¿¡¼­ Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀÌ´Â ÀÇ·Ú Áõ°¡¿Í Æø³ÐÀº ¼ö¿ëÀ¸·Î À̾îÁö°í ÀÖ½À´Ï´Ù. ´Ù¼¸Â°, °­·ÂÇÑ Á¤Ã¥Àû Áö¿ø, ¼¼°èº¸°Ç±â±¸ÀÇ ÀÚ±Ý Áö¿ø ¾à¼Ó, ±×¸®°í º¸ÆíÀû ÀǷẸÇèÀÇ Æ²¿¡ PPC°¡ Æ÷ÇԵʿ¡ µû¶ó ¾Æµ¿ º¸°Ç ½Ã½ºÅÛ¿¡¼­ PPCÀÇ ¿ªÇÒÀÌ Á¦µµÈ­µÇ°í ÀÖ½À´Ï´Ù. ¸¶Áö¸·À¸·Î Àΰ£ Áß½ÉÀû µ¹º½¿¡ ´ëÇÑ »çȸÀû º¯È­¿Í ¼Ò¾Æ ȯÀÚÀÇ Á¤¼­Àû, ½ÇÁ¸Àû Çʿ信 ´ëÇÑ ÀνÄÀÌ ÁßÁõ ¼Ò¾Æ ȯÀÚ Ä¡·á¿¡ ´ëÇÑ Global Industry AnalystsÀÇ Á¢±Ù ¹æ½ÄÀ» º¯È­½Ã۰í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀÌ º¹ÇÕÀûÀ¸·Î ÀÛ¿ëÇÏ¿© ¼Ò¾Æ ¿ÏÈ­Ä¡·á ºÐ¾ß´Â Àü ¼¼°è ÇコÄÉ¾î ¿ì¼±¼øÀ§ÀÇ ÁøÈ­¸¦ ¹Ý¿µÇÏ´Â Áß¿äÇÑ ¼ºÀå ºÐ¾ß·Î ÀÚ¸®¸Å±èÇϰí ÀÖ½À´Ï´Ù.

ºÎ¹®

Áúȯ À¯Çü(HIV, Á¶»ê¡¤¿Ü»ó, ¼±Ãµ ±âÇü, Áßµ¶¡¤¿ÜÀÎ, ±âŸ Áúȯ À¯Çü), ÃÖÁ¾»ç¿ëÀÚ(º´¿ø¡¤Áø·á¼Ò ÃÖÁ¾»ç¿ëÀÚ, ÀçÅà ÃÖÁ¾»ç¿ëÀÚ, Áö¿ª»çȸ ÃÖÁ¾»ç¿ëÀÚ)

Á¶»ç ´ë»ó ±â¾÷ÀÇ ¿¹

AI ÅëÇÕ

Global Industry Analysts´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI Åø¿¡ ÀÇÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â ÀϹÝÀûÀÎ LLM³ª ¾÷°èº° SLM Äõ¸®¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ´ë·® ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»ç ¼ÒÀçÁö, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±âÁØÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÔ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº Ç϶ô, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû, °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå °³¿ä

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Pediatric Palliative Care Market to Reach US$21.6 Billion by 2030

The global market for Pediatric Palliative Care estimated at US$11.3 Billion in the year 2024, is expected to reach US$21.6 Billion by 2030, growing at a CAGR of 11.4% over the analysis period 2024-2030. HIV, one of the segments analyzed in the report, is expected to record a 11.2% CAGR and reach US$9.0 Billion by the end of the analysis period. Growth in the Premature Birth & Trauma segment is estimated at 13.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.1 Billion While China is Forecast to Grow at 15.4% CAGR

The Pediatric Palliative Care market in the U.S. is estimated at US$3.1 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$4.5 Billion by the year 2030 trailing a CAGR of 15.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 8.3% and 10.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.0% CAGR.

Global Pediatric Palliative Care Market - Key Trends & Drivers Summarized

Why Is Pediatric Palliative Care Gaining Urgency in Global Child Health Services?

Pediatric palliative care (PPC) is becoming increasingly vital in modern healthcare systems, as more children are living with life-limiting and life-threatening conditions due to advancements in neonatal and pediatric care. Unlike adult palliative care, which primarily focuses on end-of-life support, PPC begins at diagnosis and runs concurrently with curative treatment, emphasizing holistic care-physical, emotional, psychological, and spiritual-for both the child and their family. Conditions such as congenital anomalies, pediatric cancers, severe neurological disorders, metabolic diseases, and rare genetic syndromes require ongoing, comprehensive care plans that prioritize comfort, dignity, and quality of life. Globally, there are an estimated 21 million children in need of palliative care annually, yet access remains highly inequitable, particularly in low- and middle-income countries. The growing recognition of children's rights to pain relief, psychosocial support, and compassionate care is prompting governments, NGOs, and healthcare institutions to expand PPC capacity. As pediatric survival improves, so does the need for sustainable models of care that acknowledge chronicity, emotional complexity, and family involvement, making PPC a critical pillar in the continuum of pediatric health services.

How Are Integrated Care Models and Multidisciplinary Teams Transforming PPC Delivery?

The delivery of pediatric palliative care is evolving through the adoption of integrated care models and interdisciplinary collaboration designed to address the multifaceted needs of pediatric patients and their families. Unlike traditional healthcare delivery, PPC involves a close-knit team comprising pediatricians, nurses, pain specialists, psychologists, social workers, chaplains, and palliative care experts who work together to support every aspect of a child’s well-being. These teams coordinate with primary care and specialty services-including oncology, cardiology, neurology, and intensive care units-to ensure continuity across all settings: hospitals, hospices, and increasingly, the child’s home. The rise of home-based palliative care services, supported by telehealth and remote monitoring, is allowing children to receive high-quality, personalized care in familiar environments, minimizing hospital stays and maximizing comfort. Additionally, family-centered care is at the heart of PPC delivery, with parents and caregivers included in decision-making processes and bereavement support. Education and training for healthcare professionals are also expanding, with institutions offering PPC-focused curricula and certifications to improve skillsets and standardize care. This comprehensive, empathetic, and collaborative approach is setting new benchmarks in pediatric healthcare, reflecting the complexity and sensitivity required in caring for seriously ill children.

What Role Do Global Health Policy, Advocacy, and Equity Play in PPC Development?

Global health policy, humanitarian advocacy, and the push for equitable access are playing significant roles in the development of pediatric palliative care services. International organizations such as the World Health Organization (WHO), UNICEF, and the International Children’s Palliative Care Network (ICPCN) are driving policy frameworks that encourage countries to integrate PPC into national health strategies. These efforts are supported by evidence demonstrating that palliative care is not only a medical necessity but a human right-ensuring that all children, regardless of income, geography, or diagnosis, can receive compassionate care. However, access remains highly unequal; while high-income countries are seeing the emergence of specialized PPC units and dedicated hospices, many low-resource settings still lack even basic palliative care services. In response, NGOs, philanthropic foundations, and community organizations are stepping in to fund grassroots PPC programs and build local capacity through workforce development, public awareness, and policy engagement. Additionally, increasing involvement of religious and cultural leaders is helping to reduce stigma and improve cultural acceptance of palliative care in conservative or underserved communities. As global focus intensifies on reducing childhood suffering and promoting equitable care access, policy, funding, and advocacy will remain pivotal in scaling and institutionalizing pediatric palliative care worldwide.

What Are the Key Drivers of Growth in the Pediatric Palliative Care Market?

The growth in the pediatric palliative care market is driven by several critical factors related to disease prevalence, healthcare advancement, policy integration, and shifting societal values. First, the increasing survival rates of children with chronic and complex medical conditions are creating a larger population in need of long-term palliative support. Second, the expansion of pediatric subspecialties-such as pediatric oncology, neurology, and neonatology-is fueling demand for palliative expertise that complements curative care across the disease continuum. Third, the growing adoption of home-based and community-centered care models, supported by digital health platforms, is making PPC more scalable and accessible. Fourth, there is a global rise in awareness and education surrounding the benefits of early palliative care intervention, not only at end-of-life but throughout the course of illness, leading to increased referrals and broader acceptance. Fifth, strong policy endorsements, funding commitments from global health agencies, and the inclusion of PPC in universal health coverage frameworks are institutionalizing its role in child health systems. Finally, the societal shift toward compassionate, human-centered care and recognition of pediatric patients’ emotional and existential needs is reshaping how we approach treatment for children with serious illness. Together, these drivers are establishing pediatric palliative care as a crucial and growing field that reflects the evolving priorities of global healthcare.

SCOPE OF STUDY:

The report analyzes the Pediatric Palliative Care market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Disease Type (HIV, Premature Birth & Trauma, Congenital Malformations, Injury Poisoning & External Causes, Other Disease Types); End-Use (Hospitals & Clinics End-Use, Home-based End-Use, Community Settings End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 47 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â